Top 4 Small-Cap Stocks In The Biotechnology Industry With The Highest Cash
Below are the top small-cap biotechnology stocks on the NYSE and the NASDAQ in terms of cash.
Dendreon Corp (NASDAQ: DNDN) had $497.54 million in total cash and $573.82 million in total debt for the latest quarter.
ViroPharma Inc (NASDAQ: VPHM) had $473.36 million in total cash and $155.46 million in total debt for the latest quarter.
Momenta Pharmaceuticals Inc (NASDAQ: MNTA) had $382.26 million in total cash and no debt for the latest quarter.
Nektar Therapeutics (NASDAQ: NKTR) had $382.11 million in total cash and $228.85 million in total debt for the latest quarter.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Biotechnology Industry highest cash small-capTrading Ideas
